Want to see QTRX full AI Analyst Report?

Quanterix (QTRX) Price & Analysis

380 Followers

QTRX Stock Chart & Stats

$3.50

-$0.25(-2.12%)

At close: Jan 08 4:00 PM EST

$3.50

-$0.25(-2.12%)

Day’s Range― - ―

52-Week Range$2.40 - $8.77

Previous CloseN/A

Volume125.22K

Average Volume (3M)509.80K

Market Cap

$203.97M

Enterprise Value$134.82M

Total Cash (Recent Filing)$99.27M

Total Debt (Recent Filing)$35.34M

Price to Earnings (P/E)―

Beta1.20

Next Earnings

Aug 10, 2026

EPS Estimate

-0.4

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-2.36

Shares Outstanding47,105,980

10 Day Avg. Volume461,526

30 Day Avg. Volume509,801

Financial Highlights & Ratios

PEG Ratio-0.02

Price to Book (P/B)0.92

Price to Sales (P/S)1.96

P/FCF Ratio-3.40

Enterprise Value/Market Cap0.66

Enterprise Value/Revenue0.93

Enterprise Value/Gross Profit2.11

Enterprise Value/Ebitda-1.59

Forecast

1Y Price Target

$4.00

Price Target Upside14.29% Upside

Rating ConsensusHold

Number of Analyst Covering2

EPS Forecast (FY)-1.48

Revenue Forecast (FY)$169.93M

Bulls Say, Bears Say

Bulls Say

Strong Liquidity, No DebtA cash balance of ~$102.6M and management’s expectation of ending 2026 with ~ $100M and no debt materially lengthens runway, reducing refinancing risk and supporting continued investment in commercialization and diagnostics while pursuing H2 cash‑flow breakeven.

Low Leverage / Healthy Balance SheetLow debt-to-equity (~0.11–0.13) provides financial flexibility to fund product development, M&A integration, and commercialization without heavy interest burdens, helping the company absorb operating losses while executing its strategic plan.

Installed Base, High Gross Margins, Delivered SynergiesA >2,300 instrument installed base creates recurring consumables pull‑through (razor‑and‑blades model); robust non‑GAAP gross margins (~50%+) and the realization of $85M in Akoya synergies improve unit economics and sustainability of consumables-driven revenue.

Bears Say

Persistent Cash BurnSustained negative operating and free cash flow (TTM) indicates ongoing cash burn that will require either sustained margin improvement or external financing to fund operations, limiting strategic optionality until durable cash‑flow positivity is achieved.

Large, Persistent Losses And Weak MarginsDeep negative margins and substantial net losses reflect challenged profitability and weak operating leverage; unless structural revenue mix shifts or meaningful cost reductions persist, the company faces continued erosion of shareholder equity and limited near‑term free cash generation.

Material Organic Demand Weakness In Core MarketsSignificant organic declines across flagship Simoa and spatial platforms and a steep drop in pharma revenue signal structural weakness in end markets and slower instrument placements, constraining recurring consumables growth and making reliance on acquisitions or partners riskier for sustained revenue expansion.

Quanterix News

Quanterix appoints Faessler as Chief Financial Officer

Quanterix (QTRX) announced the appointment of Jason Faessler as the Company’s new Chief Financial Officer, effective June 22....

25d ago

BRKR

QTRX

Quanterix appoints Geoff Albrecht as general manager, Diagnostics

Quanterix Corporation (QTRX) announced the appointment of Geoff Albrecht as Senior Vice President and General Manager of Diagnostics....

30d ago

DGX

QTRX

Quanterix Shareholders Reject Equity Plan at 2026 Meeting

Quanterix ( ($QTRX) ) has provided an update. At Quanterix Corporation’s 2026 Annual Meeting of Stockholders held on...

23d ago

QTRX

Quanterix Appoints Jason Faessler as New Chief Financial Officer

Quanterix ( ($QTRX) ) just unveiled an update. On June 9, 2026, Quanterix announced the appointment of Jason...

25d ago

QTRX

Quanterix Reshapes Leadership, Appoints Anthony Catalano COO

Quanterix ( ($QTRX) ) has provided an announcement. On May 14, 2026, Quanterix Corporation appointed Anthony Catalano as...

1M ago

QTRX

Quanterix Earnings Call Balances Growth And Strain

Quanterix (($QTRX)) has held its Q1 earnings call. Read on for the main highlights of the call. Quanterix’s...

2M ago

QTRX

Quanterix announces CFO transition

Quanterix (QTRX) “announced that Vandana Sriram, its CFO will depart the Company. A search for her successor is...

2M ago

QTRX

Quanterix Announces CFO Transition and Leadership Succession Plan

Quanterix ( ($QTRX) ) has provided an update. Quanterix announced on May 12, 2026, that Chief Financial Officer...

2M ago

QTRX

Quanterix Balances Growth Ambitions with Organic Weakness

Quanterix (($QTRX)) has held its Q1 earnings call. Read on for the main highlights of the call. Quanterix’s...

2M ago

QTRX

Quanterix price target lowered to $4 from $7 at TD Cowen

TD Cowen lowered the firm’s price target on Quanterix (QTRX) to $4 from $7 and keeps a Hold...

2M ago

QTRX

Lucent Diagnostics announces collaboration with Tempus AI

Lucent Diagnostics, a brand of Quanterix Corporation (QTRX), announced a collaboration with Tempus AI (TEM) to broaden access...

2M ago

TEM

QTRX

Quanterix reports Q1 EPS (37c), consensus (62c)

Reports Q1 revenue $36.4M, consensus $36.84M. The company said, “”We continue to make progress toward achieving cash flow...

2M ago

QTRX

Quanterix affirms 2026 revenue outlook $169M-$174M

The company said, “Quanterix (QTRX) is reaffirming its guidance for 2026. The Company expects revenues of $169 to...

2M ago

QTRX

Quanterix Reports Strong Q1 Growth and Alzheimer’s Progress

The latest update is out from Quanterix ( ($QTRX) ). On May 6, 2026, Quanterix reported first-quarter 2026...

2M ago

QTRX

QTRX FAQ

What was Quanterix Corporation’s price range in the past 12 months?

Quanterix Corporation lowest stock price was $2.40 and its highest was $8.77 in the past 12 months.

What is Quanterix Corporation’s market cap?

Quanterix Corporation’s market cap is $203.97M.

When is Quanterix Corporation’s upcoming earnings report date?

Quanterix Corporation’s upcoming earnings report date is Aug 10, 2026 which is in 37 days.

How were Quanterix Corporation’s earnings last quarter?

Quanterix Corporation released its earnings results on May 06, 2026. The company reported -$0.37 earnings per share for the quarter, beating the consensus estimate of -$0.513 by $0.143.

Is Quanterix Corporation overvalued?

According to Wall Street analysts Quanterix Corporation’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Quanterix Corporation pay dividends?

Quanterix Corporation does not currently pay dividends.

What is Quanterix Corporation’s EPS estimate?

Quanterix Corporation’s EPS estimate is -0.4.

How many shares outstanding does Quanterix Corporation have?

Quanterix Corporation has 47,105,980 shares outstanding.

What happened to Quanterix Corporation’s price movement after its last earnings report?

Quanterix Corporation reported an EPS of -$0.37 in its last earnings report, beating expectations of -$0.513. Following the earnings report the stock price went down -16.413%.

Which hedge fund is a major shareholder of Quanterix Corporation?

Currently, no hedge funds are holding shares in QTRX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Quanterix Stock Smart Score

Neutral

Fundamentals

Return on Equity

-35.17%

Trailing 12-Months

Asset Growth

-7.53%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Quanterix Corporation

Quanterix Corporation, based in Billerica, Massachusetts, is a life sciences enterprise dedicated to pioneering and commercializing advanced digital immunoassay platforms. These sophisticated systems are designed to enhance precision health in both scientific research and diagnostic applications, reaching markets across North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company's core offerings include several innovative instruments: The HD-X instrument, which provides highly sensitive and automated multiplex protein detection. The SR-X instrument, enabling researchers to leverage Simoa detection technology for diverse uses, such as the direct detection of nucleic acids. The SP-X instrument, which utilizes Simoa planar array technology for conducting multiplex chemiluminescent immunoassays. Alongside these platforms, Quanterix also supplies crucial consumables, including assay kits and reagents. In addition to its product line, the company delivers various contract research services, encompassing sample analysis, the development of custom "homebrew" assays, and other specialized research and development projects. Quanterix's operational focus spans critical health areas like neurology, oncology, cardiology, infectious diseases, and inflammation. Its clientele within the life science research sector primarily consists of laboratories affiliated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research organizations. Sales are managed through a multifaceted approach, combining a direct sales force, dedicated support organizations, and a network of distributors or sales agents. The company was initially incorporated in 2007 as Digital Genomics, Inc., before rebranding to Quanterix Corporation in August of the same year.

Quanterix (QTRX) Earnings & Revenues

Historic Earnings Reports

QTRX Company Deck

QTRX Earnings Call

Q1 2026

0:00 / 0:00

Earnings Call Sentiment|Neutral

The call mixed encouraging operational and financial progress—an increase in reported revenue, strong non-GAAP gross margins above 50%, delivery of $85M in synergies, a healthy cash balance (~$102.6M), and clear strategic investments in commercial capabilities and diagnostics (HD-X IVD push, Tempus partnership). Offsetting these positives are material organic revenue declines (Simoa -21%, spatial -26%), a 33% drop in pharma revenue, softer-than-expected instrumentation sales, and notable one-time acquisition-related charges. Management maintained full-year guidance and outlined concrete steps to drive H2 improvement and cash-flow breakeven, but near-term execution and end-market recovery remain key risks.View all QTRX earnings summaries

QTRX Stock 12 Month Forecast

Average Price Target

$4.00

▲(14.29% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"$2","7":"$7","3.25":"$3.25","4.5":"$4.5","5.75":"$5.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$4.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,3.25,4.5,5.75,7],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.5,3.5384615384615383,3.576923076923077,3.6153846153846154,3.6538461538461537,3.6923076923076925,3.730769230769231,3.769230769230769,3.8076923076923075,3.8461538461538463,3.8846153846153846,3.9230769230769234,3.9615384615384617,{"y":4,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.5,3.5384615384615383,3.576923076923077,3.6153846153846154,3.6538461538461537,3.6923076923076925,3.730769230769231,3.769230769230769,3.8076923076923075,3.8461538461538463,3.8846153846153846,3.9230769230769234,3.9615384615384617,{"y":4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.5,3.5384615384615383,3.576923076923077,3.6153846153846154,3.6538461538461537,3.6923076923076925,3.730769230769231,3.769230769230769,3.8076923076923075,3.8461538461538463,3.8846153846153846,3.9230769230769234,3.9615384615384617,{"y":4,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.25,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.69,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.86,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.49,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5.54,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":5.34,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6.97,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6.36,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6.5,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":6.33,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.48,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.4,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":3.5,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >